Home
About
Overview
Sharing Data
ORCID
Help
History (40)
Natural Cytotoxicity Triggering Receptor 2
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
Identification of a region in G protein gamma subunits conserved across species but hypervariable among subunit isoforms.
Systemic translocation of Staphylococcus drives autoantibody production in HIV disease.
Cochlear Immune Response in Presbyacusis: a Focus on Dysregulation of Macrophage Activity.
See All 40 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cochlear Immune Response in Presbyacusis: a Focus on Dysregulation of Macrophage Activity.
Cochlear Immune Response in Presbyacusis: a Focus on Dysregulation of Macrophage Activity. J Assoc Res Otolaryngol. 2022 02; 23(1):1-16.
View in:
PubMed
subject areas
Aged
Animals
Cochlea
Hearing Loss, Sensorineural
Humans
Immunity
Macrophages
Mice
Presbycusis
authors with profiles
Hainan Lang